Trial intelligence / Profile preview

Epidural corticosteroid injection for subacute pain control following bilateral total knee arthroplasty

TCTR20230111002Phase 3Completed

Sponsor
Setthawut Suppiumlarp
Start
May 2021
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pain (2 arms), sponsored by Setthawut Suppiumlarp. Primary endpoint: Subacute postoperative pain. Started May 2021; status: completed.

02

Conditions

pain

Beyond the preview

Go deeper on TCTR20230111002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230111002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call